Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Early diagnosis and staging of prostate cancer.

Literature DB >> 16985972

Early diagnosis and staging of prostate cancer.

Abstract

The need for accurate methods of ascertaining the malignant potential of any given man's prostate cancer has never been greater than it is today. The presenters at the session of the 13th International Prostate Cancer Update addressing early diagnosis and staging of disease discussed combined-modality staging of disease; color Doppler imaging for detection of cancer; pelvic lymphadenectomy as a diagnostic tool; and a new, artificial intelligence-based model to predict survival. A summary of these presentations is provided here.

Entities: Disease

Year: 2003 PMID： 16985972 PMCID： PMC1502371

Source DB: PubMed Journal: Rev Urol ISSN： 1523-6161

22 in total

1. Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy.

Authors: S Borirakchanyavat; V Bhargava; K Shinohara; A Toke; P R Carroll; J C Presti
Journal: Urology Date: 1997-09 Impact factor: 2.649

2. Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml.

Authors: A V D'Amico; R Whittington; I Kaplan; C Beard; M Jiroutek; S B Malkowicz; A Wein; C N Coleman
Journal: Int J Radiat Oncol Biol Phys Date: 1997-03-15 Impact factor: 7.038

3. Natural history of progression after PSA elevation following radical prostatectomy.

Authors: C R Pound; A W Partin; M A Eisenberger; D W Chan; J D Pearson; P C Walsh
Journal: JAMA Date: 1999-05-05 Impact factor: 56.272

4. Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation.

Authors: G E Hanks; W R Lee; T E Schultheiss
Journal: J Urol Date: 1995-08 Impact factor: 7.450

5. The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer.

Authors: P Narayan; V Gajendran; S P Taylor; A Tewari; J C Presti; R Leidich; R Lo; K Palmer; K Shinohara; J T Spaulding
Journal: Urology Date: 1995-08 Impact factor: 2.649

6. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma.

Authors: H Ragde; J C Blasko; P D Grimm; G M Kenny; J E Sylvester; D C Hoak; K Landin; W Cavanagh
Journal: Cancer Date: 1997-08-01 Impact factor: 6.860

7. Comparison of microscopic vascularity in benign and malignant prostate tissue.

Authors: S A Bigler; R E Deering; M K Brawer
Journal: Hum Pathol Date: 1993-02 Impact factor: 3.466

8. Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy.

Authors: A W Partin; S Piantadosi; M G Sanda; J I Epstein; F F Marshall; J L Mohler; C B Brendler; P C Walsh; J W Simons
Journal: Urology Date: 1995-05 Impact factor: 2.649